Breast Cancer
Study results from Harvard University, Medical Department update understanding of breast cancer
Published in Cancer Weekly, May 26th, 2009
"A major effector of PI3K is Akt/protein kinase B (PKB). Recent studies have pointed to distinct roles of Akt/PKB Isoforms in cancer cell signaling. Studies have shown that Akt1 (PKB alpha) can attenuate breast cancer cell motility, whereas Akt2 (PKB beta) enhances this phenotype. Here, we have evaluated the mechanism by which Akt1 blocks the migration of breast cancer cells through the transcription factor NFAT. A major effector of Akt/PKB Is glycogen synthase kInase-3...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-05-26)
More Articles from Cancer Weekly
- Advaxis, Inc.
Advaxis Scientific Founder Published in Prestigious Peer-Reviewed Journal of Immunology - Cancer
Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa - Cancer Gene Therapy
Data on cancer gene therapy published by J.A. Westwood and colleagues - Cancer Gene Therapy
Research from Harvard University has provided new data on cancer gene therapy - Cancer Vaccines
Data from H. West and colleagues advance knowledge in cancer vaccines - Cancer Vaccines
Investigators at Radboud University release new data on cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
